VitaDX has just closed its third round of financing of €4 million from three seed funds GO CAPITAL Auriga Partners and ODYSSEE VENTURE as well as Pierre-Yves Divet (FFBB Management).

This will allow VitaDX to finalize the development and ensure the commercial deployment of its first early bladder cancer detection solution.

Read the press release